Peter Gmeiner

13.3k citations

341 papers · 10.5k indexed · 5 hit papers · h-index 48

Impact in

Cellular and Molecular Neuroscience top 0.2%
- Neuropeptides and Animal Physiology
- Neurotransmitter Receptor Influence on Behavior
Molecular Biology top 0.5%
- Receptor Mechanisms and Signaling
- Chemical Synthesis and Analysis
- Pharmacological Receptor Mechanisms and Effects

Papers in

Cellular and Molecular Neuroscience 138
- Neuropeptides and Animal Physiology 84
- Neurotransmitter Receptor Influence on Behavior 32
- Neuroscience and Neuropharmacology Research 26
Organic Chemistry 131
- Click Chemistry and Applications 30

Co-authors: Harald Hübner Stefan Löber Brian K. Kobilka Ralf C. Kling Jürgen Einsiedel Frank M. Boeckler Aashish Manglik William I. Weis
Journals: Journal of Medicinal Chemistry (52 papers)Bioorganic & Medicinal Chemistry (27 papers)Bioorganic & Medicinal Chemistry Letters (26 papers)Archiv der Pharmazie (18 papers)Synthesis (11 papers)
Partner nations: Germany United States United Kingdom

In The Last Decade

Peter Gmeiner

334 papers receiving 10.3k citations

Hit Papers

5 papers align trajectories log scale

Time-resolved cryo-EM of G-protein activation by a GPCR 2024 · 53 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2024 Nature
2016 Nature
2015 Nature
2013 Nature
2011 Nature

Peers

Countries citing papers authored by Peter Gmeiner

Since Specialization

Citations

This map shows the geographic impact of Peter Gmeiner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Gmeiner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Gmeiner more than expected).

Fields of papers citing papers by Peter Gmeiner

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Gmeiner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Gmeiner. The network helps show where Peter Gmeiner may publish in the future.

Co-authors

The 25 scholars most cited alongside Peter Gmeiner, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Peter Gmeiner Line = papers co-authored together Peter Gmeiner links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	A Putative Frizzled 7-Targeting Compound Acts as a Firefly Luciferase Inhibitor Journal of Medicinal Chemistry ·Sid Tepper, Lukas Grätz, Jan Voss, Β. W. Low, Edward Bradby, Baptiste Jude, Johanna T. Lanner, Stefan Löber, Peter Gmeiner, Gunnar Schulte	2024	2
2	Identification and quantification of kukoamine A and kukoamine B as novel μ-opioid receptor agonists in potato and other solanaceous plants Food Chemistry ·Howard Becker, Stella Maimone, Harald Hübner, Peter Gmeiner, Timothy Clark, Monika Pischetsrieder	2023	2
3	Constrained catecholamines gain β2AR selectivity through allosteric effects on pocket dynamics Nature Communications ·Xinyu Xu, Jeremy Shonberg, Jonas Kaindl, Mary J. Clark, Anne Stößel, Muhammad Turyalai Khan, Daniel Mayer, Harald Hübner, Kunio Hirata, AJ Venkatakrishnan, Ron O. Dror, Brian K. Kobilka, Roger K. Sunahara, Xiangyu Liu, Peter Gmeiner	2023	13
4	Therapeutic antagonism of the neurokinin 1 receptor in endosomes provides sustained pain relief Proceedings of the National Academy of Sciences ·Alan Hégron, Chloe J. Peach, Raquel Tonello, Qiu-Xia Deng, Shavonne Teng, Rocco Latorre, Boris E. Odintsov, Dorothée Weikert, Jeanette Rientjes, Nicholas A. Veldhuis, Daniel P. Poole, Dane D. Jensen, A. Thomsen, Brian L. Schmidt, Wendy L. Imlach, Peter Gmeiner, Nigel W. Bunnett	2023	22
5	Design of Drug Efficacy Guided by Free Energy Simulations of the β ₂ ‐Adrenoceptor Angewandte Chemie International Edition ·Nicolas Panel, Duc Duy Vo, Ccss Ccss, Harald Hübner, Cheng Ning, Pierre Matricon, Н. Б. Логинова, J. A. Semidara, 田建平, Andreas Luttens, Lucie Delemotte, Jan Kihlberg, Peter Gmeiner, Jens Carlsson	2023	12
6	Phosphoproteomic Analysis of Dopamine D2 Receptor Signaling Reveals Interplay of G Protein- and β-Arrestin-Mediated Effects Journal of Proteome Research ·Rajjaboyeva Feride, Shahbaz Khan, Vladimir Ignatchenko, Harald Hübner, Peter Gmeiner, Dorothée Weikert, Monika Pischetsrieder, Thomas Kislinger	2022	2
7	Structural insights into ligand recognition, activation, and signaling of the α _2A adrenergic receptor Science Advances ·Jun Xu, Sheng Cao, Harald Hübner, Dorothée Weikert, Geng Chen, Andrea Cedillo Ornelas, Daopeng Yuan, Peter Gmeiner, Zheng Liu, Yang Du	2022	22
8	Photochromic Fentanyl Derivatives for Controlled μ‐Opioid Receptor Activation Chemistry - A European Journal ·EI-Tawil, Harald Hübner, Maximilian F. Schmidt, 肖浩文, Peter Gmeiner, Burkhard König	2022	11
9	Homobivalent Dopamine D₂ Receptor Ligands Modulate the Dynamic Equilibrium of D₂ Monomers and Homo- and Heterodimers ACS Chemical Biology ·紘典北, D Alexandrides, Selcen Özcan Bulut, Lee Hoonseung, Harald Hübner, Peter Gmeiner, Dorothée Weikert	2021	13
10	Dibenzodiazepinone-type muscarinic receptor antagonists conjugated to basic peptides: Impact of the linker moiety and unnatural amino acids on M2R selectivity European Journal of Medicinal Chemistry ·Swaren LR, David Wifling, Maximilian F. Schmidt, Snooks Co. QSnooks Co., 宏浅野, Timothy Clark, Peter Gmeiner, Max Keller	2021	5
11	Investigation of Inactive-State κ Opioid Receptor Homodimerization via Single-Molecule Microscopy Using New Antagonistic Fluorescent Probes Journal of Medicinal Chemistry ·M. F. A. SOUZA, Zsombor Kőszegi, Yann Lanoiselée, Harald Hübner, Peter Gmeiner, Davide Calebiro, Michael Decker	2020	16
12	Structure-based development of caged dopamine D2/D3 receptor antagonists Scientific Reports ·D Alexandrides, Harald Hübner, Stefan Löber, Burkhard König, Peter Gmeiner	2020	16
13	Activation of the α2B adrenoceptor by the sedative sympatholytic dexmedetomidine Nature Chemical Biology ·Daopeng Yuan, Zhongmin Liu, Jonas Kaindl, Shoji Maeda, Jiawei Zhao, Xiaoou Sun, Jun Xu, Peter Gmeiner, Hongwei Wang, Brian K. Kobilka	2020	52
14	Dual-Acting Cholinesterase–Human Cannabinoid Receptor 2 Ligands Show Pronounced Neuroprotection in Vitro and Overadditive and Disease-Modifying Neuroprotective Effects in Vivo Journal of Medicinal Chemistry ·Matthias Scheiner, Enrique Uribe Leitz, Sandra Gunesch, Matthias Hoffmann, Massimo Nabissi, Oliviero Marinelli, Marina Naldi, Manuela Bartolini, Sabrina Petralla, 勇小柳, Barbara Monti, Christina Falkeis, Michael Vieth, Harald Hübner, Peter Gmeiner, Rangan Maitra, Tangui Maurice, Michael Decker	2019	39
15	Conjugation of Short Peptides to Dibenzodiazepinone-Type Muscarinic Acetylcholine Receptor Ligands Determines M₂R Selectivity Journal of Medicinal Chemistry ·M Owens, David Wifling, A M G M Yapabandarab, kata o'qituvchisi Ahadova Nurafshon Rustam qizi Oʻzbekiston davlat jahon tillari universiteti xorijiy Ilmiy rahbar:Axmedjanova Dilraboxon OʻzDJTU, Harald Hübner, Günther Bernhardt, Peter Gmeiner, Max Keller	2019	10
16	Structure-Based Design and Discovery of New M₂Receptor Agonists Journal of Medicinal Chemistry ·Teresa Morais, Anne Stößel, С. В. Шкребец, Céline Valant, Kenty Kenty, Boris E. Odintsov, Dorothée Möller, Mary J. Clark, Roger K. Sunahara, Arthur Christopoulos, Brian K. Shoichet, Peter Gmeiner	2017	21
17	Structure-Guided Screening for Functionally Selective D₂ Dopamine Receptor Ligands from a Virtual Chemical Library ACS Chemical Biology ·Р. Крицький, Mariama Jaiteh, Alexey A. Zeifman, Alena Randáková, Dorothée Möller, Harald Hübner, Peter Gmeiner, Jens Carlsson	2017	33
18	Covalent agonists for studying G protein-coupled receptor activation Proceedings of the National Academy of Sciences ·Dietmar Weichert, Andrew C. Kruse, Aashish Manglik, Jenny Paola Ortega, Cheng Zhang, Harald Hübner, Brian K. Kobilka, Peter Gmeiner	2014	74
19	Functionally Selective Dopamine D ₂ , D ₃ Receptor Partial Agonists Journal of Medicinal Chemistry ·Dorothée Möller, Ralf C. Kling, Ying Yu, Kristina Leuner, Harald Hübner, Peter Gmeiner	2014	69
20	In Vivo Monitoring of the Antiangiogenic Effect of Neurotensin Receptor-Mediated Radiotherapy by Small-Animal Positron Emission Tomography: A Pilot Study Pharmaceuticals ·Simone Maschauer, S PanditAbhay, Philipp Tripal, Roland Haubner, Jürgen Einsiedel, Harald Hübner, Peter Gmeiner, Torsten Kuwert, Olaf Prante	2014	17

About Peter Gmeiner

Peter Gmeiner is a scholar working on Cellular and Molecular Neuroscience, Organic Chemistry, Molecular Biology, Pharmaceutical Science and Spectroscopy, having authored 341 papers that have together received 10.5k indexed citations. Recurring topics across this work include Receptor Mechanisms and Signaling (167 papers), Chemical Synthesis and Analysis (106 papers), Neuropeptides and Animal Physiology (84 papers), Pharmacological Receptor Mechanisms and Effects (38 papers), Neurotransmitter Receptor Influence on Behavior (32 papers), Click Chemistry and Applications (30 papers), Monoclonal and Polyclonal Antibodies Research (27 papers) and Neuroscience and Neuropharmacology Research (26 papers). The work is most often cited by research in Cellular and Molecular Neuroscience (4.5k citations), Molecular Biology (7.7k citations), Organic Chemistry (2.9k citations), Computational Theory and Mathematics (954 citations) and Radiology, Nuclear Medicine and Imaging (1.2k citations). Peter Gmeiner has collaborated with scholars based in Germany, United States and United Kingdom. Frequent co-authors include Harald Hübner, Stefan Löber, Brian K. Kobilka, Ralf C. Kling, Jürgen Einsiedel, Frank M. Boeckler, Aashish Manglik, William I. Weis, Nuška Tschammer and Olaf Prante. Their work appears in journals such as Journal of Medicinal Chemistry, Bioorganic & Medicinal Chemistry, Bioorganic & Medicinal Chemistry Letters, Archiv der Pharmazie and Synthesis.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact